Evaluation of Reference variability [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2010-03-16 17:01 (5949 d 05:23 ago) – Posting: # 4921
Views: 5,305

Dear Marcel!

❝ My apologies for dragging this replicate skeleton out of the closet when it seemed like it was comfortably resting.


No problem - if you think we need some more forensics, go for exhumation!

❝ Was there any mention at this meeting as to whether the results of a replicate design study (finding of intra-subject variablility exceeding 30%) with a lower strength can be used to justify widen acceptance limits for a higher strength of the same drug to undergo a standard BE study?


No. Or to be more precise, nobody asked that question, but I would bet the answer would have been a straight "No!" as well.

❝ If this is not allowed, can someone explain why not?


I would say there are two reasons.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
369 visitors (0 registered, 369 guests [including 77 identified bots]).
Forum time: 23:25 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5